Empire Financial Management Company, LLC Biocryst Pharmaceuticals Inc Transaction History
Empire Financial Management Company, LLC
- $302 Billion
- Q2 2024
A detailed history of Empire Financial Management Company, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Empire Financial Management Company, LLC holds 59,000 shares of BCRX stock, worth $433,650. This represents 0.12% of its overall portfolio holdings.
Number of Shares
59,000
Previous 79,000
25.32%
Holding current value
$433,650
Previous $401 Million
9.14%
% of portfolio
0.12%
Previous 0.13%
Shares
6 transactions
Others Institutions Holding BCRX
# of Institutions
257Shares Held
173MCall Options Held
397KPut Options Held
444K-
Black Rock Inc. New York, NY20MShares$147 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.8MShares$138 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.6MShares$92.4 Million1.06% of portfolio
-
State Street Corp Boston, MA9.35MShares$68.7 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.83MShares$64.9 Million4.25% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.37B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...